Drugs@FDA document
GRIFULVIN V Review · ANDA 062279 SUPPL-16
Drugs@FDA document · VALEANT LUXEMBOURG · Jul 22, 2005
Key facts
| Drug name | GRIFULVIN V |
|---|---|
| Document type | Review |
| Application | ANDA062279 |
| Submission | SUPPL-16 |
| Company | VALEANT LUXEMBOURG |
| Document date | Jul 22, 2005 |
| FDA document | accessdata.fda.gov |
At a glance
- 1–9 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: